17:53:58 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



THC Biomed Intl Ltd
Symbol THC
Shares Issued 163,676,056
Close 2023-06-20 C$ 0.035
Market Cap C$ 5,728,662
Recent Sedar Documents

THC Biomed opens THC2GO in Thailand

2023-06-20 07:35 ET - News Release

Mr. John Miller reports

THC BIOMED (THAILAND) LAUNCHES STATE-OF-THE-ART MEDICAL CANNABIS THC2GO DISPENSARY

THC Biomed Intl Ltd.'s THC Biomed (Thailand) Co. Ltd. has officially opened a THC2GO medical cannabis dispensary in Thailand. This strategic move represents a significant milestone for THC Biomed as it positions itself as a global player, tapping into the flourishing Southeast Asian market.

Because of applicable foreign ownership rules, THC Thailand is 51 per cent owned by a Thai-owned company. THC Biomed owns 49 per cent, with 9 per cent of that being held in trust by THC Biomed for an arm's-length party. Located in the vibrant city of Rawai, Phuket, the cutting-edge THC2GO medical cannabis dispensary signifies THC Biomed's unwavering commitment to delivering superior health care solutions and elevating the standards of medical cannabis treatment across international borders.

THC Thailand's THC2GO dispensary offers an extensive selection of top-tier medical cannabis products meticulously crafted to meet the most stringent quality criteria. The company's unrivalled cultivation practices and unwavering compliance with strict regulatory protocols ensure that patients receive safe, reliable and consistently exceptional cannabis offerings.

In addition to providing patients with an extensive range of high-quality medical cannabis products, THC Biomed is proud to forge strong alliances with local businesses, health care professionals, researchers and regulatory bodies. Collaborating with esteemed medical practitioners, the company aims to foster a culture of education, evidence-based practices and knowledge sharing about the remarkable potential of medical cannabis.

"We are thrilled with the opening of our state-of-the-art THC2GO medical cannabis dispensary in Thailand," said John Miller, chief executive officer of THC Biomed. "This expansion underscores our unwavering commitment to making a positive impact on global health care. We are dedicated to serving patients, fostering research initiatives and driving the medical cannabis movement forward in Thailand."

About THC Biomed Intl Ltd.

THC Biomed is one of Canada's oldest active licensed cannabis companies. It was first licensed to deal with cannabis in 2013 under a Health Canada Section 56 exemption under the Controlled Drugs and Substances Act and has been a licensed producer under the current regime since 2016. Its product focus is on high-quality, high-potency beverages and edibles.

THC Biomed is a Cannabis Act licensed producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The company is on the leading edge of scientific research and the development of products and services in the medical and recreational cannabis industry. Management believes THC Biomed is well positioned to be in the forefront of this industry.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.